Capricorn et al. invest €1.3m in Feops

Feops will use the capital injection to finance the commercialisation of its first product, Taviguide, in key markets in Europe and the US.

Capricorn has invested via its €33.2m digital healthcare fund, Capricorn ICT Arkiv, which counts Quest for Growth and ARKimedes Fund II as its cornerstone investors.

PMV has invested via its Flanders Care Invest fund, which invests up to €2m in Flemish healthcare companies, predominantly those operating within the elderly care services market.

Company
Founded in 2009 as a spinout from Ghent University, Feops develops 3D simulation technology for cardiovascular interventions.

Its Taviguide product is a cloud-based pre-operative planning service for transcatheter aortic valve implantation.

The company's products are designed to be used by cardiovascular device manufacturers and physicians.

People
Matthieu de Beule is the CEO of Feops. Marc Lambrechts is a senior investment manager at Capricorn, while Alexandra Tolia is a senior investment manager at PMV. Both have joined the company's board of directors.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Early-stage
• Benelux
• Healthcare
• Belgium